IMR — Imricor Medical Systems Balance Sheet
0.000.00%
Last trade - 00:00- AU$613.65m
- AU$590.75m
- $0.29m
Annual balance sheet for Imricor Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 18.5 | 5.69 | 0.832 | 15.7 | 40.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.095 | 0.126 | 0.393 | 0.345 | 0.241 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 22.7 | 9.68 | 3.94 | 18.3 | 42.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.6 | 3.56 | 3.17 | 2.6 | 2.14 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 26.9 | 13.7 | 8.31 | 21.6 | 45.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.74 | 2.07 | 4.57 | 2.36 | 17.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.46 | 6.19 | 17.1 | 29 | 34.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 22.4 | 7.51 | -8.75 | -7.38 | 11.5 |
| Total Liabilities & Shareholders' Equity | 26.9 | 13.7 | 8.31 | 21.6 | 45.8 |
| Total Common Shares Outstanding |